纤溶酶注射液配合血栓通在老年缺血性脑卒中的治疗效果观察

发表时间:2018/8/9   来源:《中国医学人文》2018年第6期   作者:李乃妍 王吉
[导读] 缺血性脑卒中主要是指由于脑部的供血动脉出现粥样硬化引起的,加上动脉炎、胶原性疾病引起的动脉内膜增生及肥厚。
黑龙江省第二医院  150000
  【摘要】目的 研究纤溶酶注射液配合血栓通在老年缺血性脑卒中的治疗效果。方法 选取我院2017年2月至2018年2月期间收治的75例老年缺血性脑卒中患者,随机分为对照组合治疗组, 37例老年缺血性脑卒中患者实施纤溶酶注射液治疗为对照组, 38例老年缺血性脑卒中患者加用血栓通治疗为治疗组,比较两组老年缺血性脑卒中患者之间的治疗效果。结果 治疗组老年缺血性脑卒中患者治疗后的症状缓解时间、PT、APPI、FIB等指标水平、神经功能改善率明显优于对照组老年缺血性脑卒中患者(P<0.05),统计学有意义;两组老年缺血性脑卒中患者治疗后的不良反应发生率不存在显著差异(P>0.05),统计学无意义。结论 针对老年缺血性脑卒中患者实施纤溶酶注射液配合血栓通的疗效显著,安全性较高,值得临床推广。?
  【关键词】纤溶酶注射液;血栓通;老年缺血性脑卒中?
  Objective to study the effect of Fibrinogenase Injection combined with Xueshuantong on Senile Ischemic stroke. Methods 75 elderly patients with ischemic stroke in our hospital from February 2017 to February 2018 were randomly divided into the control group, 37 cases of Senile Ischemic stroke patients were treated with Fibrinogenase Injection as the control group, and 38 cases of Senile Ischemic stroke patients were treated with thrombus in the treatment group, and the two groups were compared. The therapeutic effect of elderly patients with ischemic stroke. Results the symptoms remission time, PT, APPI, FIB, and the improvement rate of nerve function in the elderly patients with ischemic stroke were significantly better than those of the control g